Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Longboard Pharmaceuticals Inc | LBPH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 20.51 | 04:16:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 20.51 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 3.60 - 28.15 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 20.51 | USD |
Longboard Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 738.71M | 36.02M | - | 0 | -54.42M | -1.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Longboard Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LBPH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 22.00 | 22.2885 | 19.75 | 20.45 | 169,957 | -1.49 | -6.77% |
| 1 Month | 17.69 | 23.955 | 17.31 | 20.50 | 310,473 | 2.82 | 15.94% |
| 3 Months | 21.57 | 24.50 | 16.55 | 20.07 | 423,954 | -1.06 | -4.91% |
| 6 Months | 4.72 | 28.15 | 3.60 | 22.56 | 881,055 | 15.79 | 334.53% |
| 1 Year | 9.45 | 28.15 | 3.60 | 21.23 | 474,125 | 11.06 | 117.04% |
| 3 Years | 8.26 | 28.15 | 2.70 | 19.37 | 180,960 | 12.25 | 148.31% |
| 5 Years | 16.00 | 28.15 | 2.70 | 19.26 | 175,579 | 4.51 | 28.19% |
Longboard Pharmaceuticals Description
| Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659. |
